LSD
2D structural formula and 3D models of LSD | |
Systematic (IUPAC) name | |
(6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide | |
Clinical data | |
AHFS/Drugs.com | Reference |
Pregnancy cat. | C (US) |
Legal status | Prohibited (S9) (AU) Schedule III (CA) Class A (UK) Schedule I (US) Psychotropic Schedule I (UN) |
Dependence liability | Low[1] |
Routes | By mouth, under the tongue, intravenous |
Pharmacokinetic data | |
Bioavailability | 71%[2] |
Protein binding | Unknown[3] |
Metabolism | Liver (CYP450)[2] |
Half-life | 3.6 hours[2][4] |
Excretion | Kidneys[2][4] |
Identifiers | |
CAS number | 50-37-3Şablon:Cascite |
ATC code | None |
PubChem | CID 5761 |
IUPHAR ligand | 17 |
DrugBank | DB04829 |
ChemSpider | 5558Şablon:Chemspidercite |
UNII | 8NA5SWF92OŞablon:Fdacite |
ChEBI | CHEBI:6605 |
ChEMBL | CHEMBL263881 |
Synonyms | LSD, LSD-25, Acid, Delysid, others |
PDB ligand ID | 7LD (PDBe, RCSB PDB) |
Chemical data | |
Formula | Şablon:OrganicBox atomŞablon:OrganicBox atomŞablon:OrganicBox atomŞablon:OrganicBox atom |
| |
| |
Physical data | |
Melt. point | 80–85 °C (176–185 °F) |
(what is this?) (verify) |
Diyet îla hdjdbdjbddjbdidbdidveinw jdhdhdjhdhdvd jd Jbv h here mîdê asîdê lîzergî ( LSD ), [a] ku bi devkî wekî asîd jî tê zanîn, dermanek hallucînojen e. Bandorên bi gelemperî raman, hest, û hay ji derdora xwe diguhezin. [5] Halusinasyonên dîtbarî an guhdarî yên gelek bikarhêneran hene. [6] [7] Pagirtên belavbûyî, zêdebûna tansiyonê, û zêdebûna germahiya laş tîpîk in. Bandorên bi gelemperî di nav nîv saet de dest pê dikin û dikarin heya 20 demjimêran bidomînin. [8] Ew bi giranî wekî dermanek rekreasyonê an ji ber
Jxjcjdbdid dhudd d dhsbdhd d djid chides sedemên giyanî tê bikar anîn. [9] [10]
Bandorên
Çavkanî
- ^ Halpern JH, Suzuki J, Huertas PE, Passie T (7 hezîran 2014). "Hallucinogen Abuse and Dependence". Bi Price LH, Stolerman IP (edîtor). Encyclopedia of Psychopharmacology A Springer Live Reference. Heidelberg, Germany: Springer-Verlag Berlin Heidelberg. rr. 1–5. doi:10.1007/978-3-642-27772-6_43-2. ISBN 978-3-642-27772-6.
Hallucinogen abuse and dependence are known complications resulting from ... LSD and psilocybin. Users do not experience withdrawal symptoms, but the general criteria for substance abuse and dependence otherwise apply. Dependence is estimated in approximately 2 % of recent-onset users
- ^ a b c d Xeletiya çavkanî: Invalid
<ref>
tag; no text was provided for refs namedDol2015
- ^ Xeletiya çavkanî: Invalid
<ref>
tag; no text was provided for refs namedPas2008
- ^ a b Mucke HA (tîrmeh 2016). "From Psychiatry to Flower Power and Back Again: The Amazing Story of Lysergic Acid Diethylamide". Assay and Drug Development Technologies. 14 (5): 276–281. doi:10.1089/adt.2016.747. PMID 27392130.
- ^
- ^
- ^
- ^
- ^
- ^
- ^
- ^
Xeletiya çavkanî: <ref>
tags exist for a group named "lower-alpha", but no corresponding <references group="lower-alpha"/>
tag was found